交易 Rocket Pharma - RCKT CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.09 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Rocket Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 19, 2024 | 22.77 | -0.49 | -2.11% | 23.26 | 23.52 | 22.28 |
Apr 18, 2024 | 23.41 | -0.02 | -0.09% | 23.43 | 23.87 | 23.27 |
Apr 17, 2024 | 23.65 | -0.60 | -2.47% | 24.25 | 24.33 | 23.44 |
Apr 16, 2024 | 24.21 | 0.46 | 1.94% | 23.75 | 24.36 | 23.58 |
Apr 15, 2024 | 23.98 | 0.01 | 0.04% | 23.97 | 24.32 | 23.73 |
Apr 12, 2024 | 24.14 | -0.95 | -3.79% | 25.09 | 25.31 | 23.82 |
Apr 11, 2024 | 25.24 | 0.85 | 3.49% | 24.39 | 25.46 | 24.35 |
Apr 10, 2024 | 24.37 | 0.02 | 0.08% | 24.35 | 24.71 | 24.05 |
Apr 9, 2024 | 25.33 | 0.95 | 3.90% | 24.38 | 25.35 | 24.25 |
Apr 8, 2024 | 24.36 | -0.76 | -3.03% | 25.12 | 25.12 | 24.34 |
Apr 5, 2024 | 24.98 | 0.51 | 2.08% | 24.47 | 25.27 | 24.21 |
Apr 4, 2024 | 24.93 | -0.57 | -2.24% | 25.50 | 26.21 | 24.87 |
Apr 3, 2024 | 25.39 | -0.02 | -0.08% | 25.41 | 25.66 | 24.97 |
Apr 2, 2024 | 25.65 | -0.47 | -1.80% | 26.12 | 26.12 | 25.26 |
Apr 1, 2024 | 26.66 | -0.24 | -0.89% | 26.90 | 26.90 | 26.03 |
Mar 28, 2024 | 26.88 | -0.19 | -0.70% | 27.07 | 27.22 | 26.59 |
Mar 27, 2024 | 27.20 | 0.95 | 3.62% | 26.25 | 27.24 | 25.97 |
Mar 26, 2024 | 26.51 | -0.45 | -1.67% | 26.96 | 27.05 | 26.18 |
Mar 25, 2024 | 26.83 | -0.22 | -0.81% | 27.05 | 27.63 | 26.63 |
Mar 22, 2024 | 27.15 | -0.64 | -2.30% | 27.79 | 27.94 | 27.11 |
Rocket Pharma Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, May 2, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 Rocket Pharmaceuticals Inc Earnings Release Q1 2024 Rocket Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 21, 2024 | ||
時間 (UTC) 13:00 | 國家 US
| 事件 Rocket Pharmaceuticals Inc Annual Shareholders Meeting Rocket Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 224.343 | 167.248 | 134.303 | 76.151 | 71.156 |
銷售/一般/行政費用,總計 | 55.573 | 41.772 | 27.921 | 17.528 | 17.886 |
研究與開發 | 165.57 | 125.476 | 106.382 | 58.623 | 53.27 |
營業收入 | -224.343 | -167.248 | -134.303 | -76.151 | -71.156 |
利息收入(費用),非經營淨值 | 2.027 | 0.091 | -4.817 | -2.544 | -4.349 |
其他,淨值 | 0.453 | -1.912 | -0.58 | 1.425 | 0.987 |
稅前淨收入 | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 |
稅後淨收入 | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 |
未計算非常項目前的淨收益 | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 |
淨收入 | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 |
普通股股東可獲收益 (不含非經常性項目) | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 |
普通股股東可獲收益 (含非經常性項目) | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 |
攤薄淨收入 | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 |
攤薄後加權平均股 | 68.1489 | 63.2354 | 55.3807 | 49.0104 | 39.3777 |
扣除特別項目的每股攤薄盈利 | -3.25556 | -2.67364 | -2.52254 | -1.57661 | -1.89239 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -3.20861 | -2.67364 | -2.52254 | -1.57661 | -1.89239 |
異常費用(收入) | 3.2 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | 0 | 0 | 0 | |
總營業費用 | 68.757 | 62.194 | 69.082 | 58.488 | 54.21 |
銷售/一般/行政費用,總計 | 17.374 | 15.823 | 17.145 | 13.805 | 12.854 |
研究與開發 | 51.383 | 46.371 | 50.037 | 43.383 | 41.356 |
營業收入 | -68.757 | -62.194 | -69.082 | -58.488 | -54.21 |
利息收入(費用),非經營淨值 | 0.378 | 1.44 | 0.778 | 0.888 | 0.204 |
其他,淨值 | 2.678 | 2.419 | 1.581 | -0.156 | -0.396 |
稅前淨收入 | -65.701 | -58.335 | -66.723 | -57.756 | -54.402 |
稅後淨收入 | -65.701 | -58.335 | -66.723 | -57.756 | -54.402 |
未計算非常項目前的淨收益 | -65.701 | -58.335 | -66.723 | -57.756 | -54.402 |
淨收入 | -65.701 | -58.335 | -66.723 | -57.756 | -54.402 |
普通股股東可獲收益 (不含非經常性項目) | -65.701 | -58.335 | -66.723 | -57.756 | -54.402 |
普通股股東可獲收益 (含非經常性項目) | -65.701 | -58.335 | -66.723 | -57.756 | -54.402 |
攤薄淨收入 | -65.701 | -58.335 | -66.723 | -57.756 | -54.402 |
攤薄後加權平均股 | 80.4724 | 79.4535 | 76.3752 | 66.2155 | 65.4765 |
扣除特別項目的每股攤薄盈利 | -0.81644 | -0.7342 | -0.87362 | -0.87224 | -0.83086 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.81644 | -0.7342 | -0.84874 | -0.85261 | -0.83086 |
異常費用(收入) | 1.9 | 1.3 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 364.06 | 392.059 | 487.345 | 307.754 | 209.088 |
現金和短期投資 | 356.394 | 388.74 | 482.719 | 304.115 | 205.73 |
現金等價物 | 140.517 | 232.694 | 297.098 | 185.383 | 111.355 |
短期投資 | 215.877 | 156.046 | 185.621 | 118.732 | 94.375 |
預付的費用 | 7.666 | 3.319 | 4.626 | 3.639 | 3.358 |
總資産 | 551.807 | 497.02 | 590.824 | 372.121 | 251.313 |
物業/廠房/設備,總計 - 淨額 | 77.645 | 72.348 | 70.641 | 31.572 | 2.027 |
物業/廠房/設備,總計 - 總額 | 86.738 | 77.571 | 72.687 | 32.251 | 2.506 |
累計折舊,總計 | -9.093 | -5.223 | -2.046 | -0.905 | -0.479 |
其他長期資産,總計 | 1.948 | 1.798 | 2.023 | 1.98 | 1.981 |
流動負債總額 | 39.169 | 22.167 | 32.617 | 18.309 | 15.372 |
應付賬款 | |||||
預提費用 | 35.16 | 19.996 | 25.263 | 17.969 | 14.783 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 2.273 | 0.482 | 0.835 | 0.34 | 0.589 |
負債總額 | 62.121 | 42.296 | 87.305 | 64.824 | 57.276 |
長期債務總額 | 19.269 | 19.144 | 54.054 | 45.049 | 41.447 |
長期債務 | 0 | 35.066 | 45.049 | 41.447 | |
其他負債,總計 | 3.683 | 0.985 | 0.634 | 1.466 | 0.457 |
股權 | 489.686 | 454.724 | 503.519 | 307.297 | 194.037 |
普通股 | 0.791 | 0.645 | 0.61 | 0.548 | 0.452 |
額外實收資本 | 1203.07 | 946.152 | 825.794 | 489.925 | 300.253 |
留存收益(累計赤字) | -713.775 | -491.912 | -322.843 | -183.143 | -105.873 |
其他權益,總計 | -0.357 | -0.161 | -0.042 | 0.02 | -0.127 |
總負債和股東權益 | 551.807 | 497.02 | 590.824 | 372.121 | 251.313 |
已發行普通股總數 | 79.1207 | 64.5059 | 60.9964 | 54.769 | 45.1947 |
商譽,淨額 | 39.154 | 30.815 | 30.815 | 30.815 | 30.815 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
長期投資 | 43.276 | 0 | 7.402 | ||
Treasury Stock - Common | -0.047 | 0 | -0.053 | -0.668 | |
長期債務的當前部分/資本租賃 | 1.736 | 1.689 | 6.519 | ||
資本租賃義務 | 19.269 | 19.144 | 18.988 | ||
無形資産,淨額 | 25.724 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 446.865 | 312.074 | 338.033 | 364.06 | 311.131 |
現金和短期投資 | 437.171 | 307.04 | 331.084 | 356.394 | 306.534 |
現金等價物 | 225.657 | 45.076 | 64.579 | 140.517 | 196.669 |
短期投資 | 211.514 | 261.964 | 266.505 | 215.877 | 109.865 |
預付的費用 | 9.694 | 5.034 | 6.949 | 7.666 | 4.597 |
總資産 | 598.762 | 461.781 | 514.757 | 551.807 | 417.265 |
物業/廠房/設備,總計 - 淨額 | 85.679 | 82.925 | 81.09 | 77.645 | 73.51 |
物業/廠房/設備,總計 - 總額 | 98.321 | 94.347 | 91.319 | 86.738 | 81.512 |
累計折舊,總計 | -12.642 | -11.422 | -10.229 | -9.093 | -8.002 |
商譽,淨額 | 39.154 | 39.154 | 39.154 | 39.154 | 30.815 |
其他長期資産,總計 | 1.914 | 1.904 | 1.799 | 1.948 | 1.809 |
流動負債總額 | 33.476 | 34.346 | 31.206 | 39.169 | 30.181 |
預提費用 | 29.85 | 31.471 | 27.788 | 35.16 | 26.577 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 1.773 | 1.76 | 1.748 | 1.736 | 1.724 |
其他流動負債,總計 | 1.853 | 1.115 | 1.67 | 2.273 | 1.88 |
負債總額 | 57.676 | 58.811 | 55.881 | 62.121 | 49.952 |
長期債務總額 | 19.341 | 19.319 | 19.294 | 19.269 | 19.242 |
長期債務 | |||||
資本租賃義務 | 19.341 | 19.319 | 19.294 | 19.269 | 19.242 |
其他負債,總計 | 4.859 | 5.146 | 5.381 | 3.683 | 0.529 |
股權 | 541.086 | 402.97 | 458.876 | 489.686 | 367.313 |
普通股 | 0.901 | 0.805 | 0.804 | 0.791 | 0.678 |
額外實收資本 | 1440.4 | 1240.74 | 1230.32 | 1203.07 | 1014.28 |
留存收益(累計赤字) | -899.71 | -837.811 | -772.11 | -713.775 | -647.052 |
其他權益,總計 | -0.508 | -0.722 | -0.09 | -0.357 | -0.596 |
總負債和股東權益 | 598.762 | 461.781 | 514.757 | 551.807 | 417.265 |
已發行普通股總數 | 90.1466 | 80.5188 | 80.4096 | 79.1207 | 67.8388 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
無形資産,淨額 | 25.15 | 25.724 | 25.724 | 25.724 | |
長期投資 | 0 | 0 | 28.957 | 43.276 | |
Treasury Stock - Common | -0.047 | -0.047 | -0.047 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 |
經營活動産生的現金 | -178.142 | -121.163 | -74.64 | -64.663 | -53.788 |
經營活動産生的現金 | 6.266 | 5.373 | 1.145 | 0.426 | 0.33 |
非現金物品 | 31.379 | 45.919 | 48.886 | 15.907 | 16.015 |
Cash Taxes Paid | 0 | 0 | 0.026 | 0.002 | |
已付現金利息 | 0 | 0.148 | 2.96 | 2.99 | 4.485 |
營運資金的變化 | 6.076 | -3.386 | 15.029 | -3.726 | 4.385 |
投資活動産生的現金 | -69.326 | 18.853 | -96.591 | -39.011 | -5.272 |
資本支出 | -8.619 | -7.715 | -29.059 | -23.269 | -1.453 |
其他投資現金流量項目,總計 | -60.707 | 26.568 | -67.532 | -15.742 | -3.819 |
融資活動産生的現金 | 155.288 | 37.681 | 282.989 | 177.791 | 153.502 |
股票的發行(報廢),淨額 | 155.288 | 37.681 | 283.84 | 178.135 | 153.502 |
債務的發行(退還),淨額 | 0 | 0 | |||
現金淨變化 | -92.18 | -64.629 | 111.758 | 74.117 | 94.442 |
融資現金流項目 | 0 | 0 | -0.851 | -0.344 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -58.335 | -221.863 | -155.14 | -97.384 | -42.982 |
Cash From Operating Activities | -57.56 | -178.142 | -122.121 | -78.262 | -39.223 |
Cash From Operating Activities | 1.673 | 6.266 | 4.488 | 2.868 | 1.302 |
Non-Cash Items | 6.572 | 31.379 | 22.625 | 14.793 | 6.887 |
Cash Interest Paid | 0 | 0 | 0 | 0 | |
Changes in Working Capital | -7.47 | 6.076 | 5.906 | 1.461 | -4.43 |
Cash From Investing Activities | -36.721 | -69.326 | 39.259 | 15.794 | -62.995 |
Capital Expenditures | -3.022 | -8.619 | -5.355 | -4.852 | -1.955 |
Other Investing Cash Flow Items, Total | -33.699 | -60.707 | 44.614 | 20.646 | -61.04 |
Cash From Financing Activities | 18.343 | 155.288 | 46.848 | 17.322 | 0.076 |
Issuance (Retirement) of Stock, Net | 18.343 | 155.288 | 46.848 | 17.322 | 0.076 |
Issuance (Retirement) of Debt, Net | |||||
Net Change in Cash | -75.938 | -92.18 | -36.014 | -45.146 | -102.142 |
Financing Cash Flow Items | 0 | ||||
Cash Taxes Paid |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
350 5th Ave Ste 7530
NEW YORK
NEW YORK 10118-7501
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易